FDA Inspection 1044005 — Luis Serentill
The FDA completed an inspection of Luis Serentill on Mar 1, 2018 in Miami Lakes, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 1, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Miami Lakes, FL (United States)
Additional Details
Clinical Investigator (CI)